Kane Biotech Expands its Wound Care and Surgical Portfolio with a coactiv+TM Antimicrobial Hydrogel Jul 22, 2021
Kane Biotech announces two key milestones as DispersinB® wound care project advances towards human clinical trials Jul 13, 2021
Kane Biotech Announces Adoption of Performance and Restricted Share Unit Plan and Amended and Restated Stock Option Plan Jun 9, 2021
Kane Biotech to Release First Quarter 2021 Financial Results on May 27 – Conference Call to Follow May 20, 2021
